๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for acute myeloid leukemia

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents NCT05442216Phase 27 sites๐Ÿ“ Miami๐Ÿ“ Orlando๐Ÿ“ Buffalo Joshua Zeidner ยท Tests: Tagraxofusp, Azacitidine, Venetoclax Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant NCT03921047n/a1 site๐Ÿ“ Los Angeles University of Southern California ยท Tests: Biospecimen Collection, Laboratory Biomarker Analysis A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites๐Ÿ“ Phoenix๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia NCT06429449Phase 11 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Venetoclax, Azacitidine, Mitoxantrone Intermediate-dose HAD Regimen for CEBPA Double-mutated AML NCT06529250NA1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: HAD, Daunorubicin+Cytarabine A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. NCT04275518Phase 114 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Ascentage Pharma Group Inc. ยท Tests: APG-115, Azacitidine, Cytarabine Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias NCT06994676Phase 111 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Tampa Crossbow Therapeutics, Inc. ยท Tests: CBX-250 Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia NCT06386302NA1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Chidamide, Venetoclax, azacitidine A Phase โ… b/โ…ก Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML NCT05133882Phase 1, Phase 21 site๐Ÿ“ Hanzhou Sunshine Lake Pharma Co., Ltd. ยท Tests: Clifutinib Besylate Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant NCT06996119Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Busulfan, Computed Tomography, Cyclophosphamide, Echocardiography Test Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen NCT06532084Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Sorafenib A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML) NCT05834244Phase 12 sites๐Ÿ“ Cleveland๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Azacitidine, Venetoclax, NK Cells CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT04493164Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ivosidenib, Liposome-encapsulated Daunorubicin-Cytarabine Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation NCT06138587Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Cytokine Induced Memory-like Natural Killer Cells, Interleukin-2 Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse NCT05270200Phase 1, Phase 21 site๐Ÿ“ Guanzhou Zhujiang Hospital ยท Tests: Azacitidine, Chidamide Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML NCT04168502Phase 348 sites๐Ÿ“ Alessandria๐Ÿ“ Ancona๐Ÿ“ Ascoli Piceno Gruppo Italiano Malattie EMatologiche dell'Adulto ยท Tests: Gemtuzumab Ozogamicin A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Phoenix Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) A Telehealth Advance Care Planning Intervention NCT05875805NA1 site๐Ÿ“ Rochester University of Rochester ยท Tests: Telehealth Serious Illness Care Program, Education Control Halt Aging in Survivors of Blood Cancers NCT07292272NA1 site๐Ÿ“ Omaha University of Nebraska ยท Tests: Behavioral Coaching Intervention, Virtual Exercise Platform Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML NCT07304232Phase 25 sites๐Ÿ“ Shijiazhuang๐Ÿ“ Harbin๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Chidamide A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML NCT06329999NA1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: CMGV Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia NCT04659616Phase 12 sites๐Ÿ“ Portland๐Ÿ“ Dallas OHSU Knight Cancer Institute ยท Tests: Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy, Cytarabine, Daunorubicin CAV Regimen for R/R AML NCT05657639Phase 21 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: CAV Regimen, MEC Regimen CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia NCT06696846Phase 11 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: CD70 CAR-NK Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor NCT07238712Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Ruxolitinib, Abatacept (Orencia) Motixafortide for MRD Sensitization in AML NCT07392970Phase 21 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Motixafortide Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation NCT06793410Phase 25 sites๐Ÿ“ Lund๐Ÿ“ Stockholm๐Ÿ“ Uppsala Vastra Gotaland Region ยท Tests: Early start post-transplant vaccination with Gardasil 9ยฎ, Late post-transplant vaccination with Gardasil 9ยฎ A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies NCT06906380n/a3 sites๐Ÿ“ Charlotte๐Ÿ“ Winston-Salem๐Ÿ“ Houston ARCE Therapeutics, Inc. ยท Tests: Non interventional study Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT NCT03793517Phase 2, Phase 31 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Decitabine, mBU/CY and ATG, mBU/CY
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy